Tying early vitamin supplementation to asthma and allergy

Once-daily icotrokinra versus placebo demonstrated clinically significant skin clearance in those with moderate-to-severe plaque psoriasis.

The final episode in our podcast series on atypical anorexia discusses fat bias in health care and its impact on diagnosis and when pushback against diagnosis happens.

A target action date for potential approval of prademagene zamikeracel (pz-cel) has been set for April 29, 2025.

Dr. Erin Harrop discusses the necessity of understanding that eating disorders do not all look the same in every patient and how a multidisciplinary approach could be an effective way to diagnose and manage anorexia nervosa that is atypical.

Colleen Sloan, PA-C, RDN, shares her tips for navigating the holidays while keeping an eye on your patients' nutrition.

In all, 51.9% of patients entered with or achieved complete disease clearance at least once during the 48-week study.